Metharbital

Metharbital
	File:Metharbital.png
Clinical data
ATC code	N03AA30 (WHO) ;
Identifiers
	IUPAC name 5,5-diethyl-1-methyl-hexahydropyrimidine-2,4,6-trione;
CAS Number	50-11-3;
PubChem CID	4099;
DrugBank	APRD00757;
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
Formula	C9H14N2O3
Molar mass	198.219 g/mol

Metharbital was patented in 1905 by Emil Fischer working for Merck^[1]. It was marketed as Gemonil by Abbott Laboratories. It is a barbiturate anticonvulsant, used in the treatment of epilepsy. It has similar properties to phenobarbital.

History

The Treatment of Epilepsy 2nd Ed by S. D. Shorvon (Editor), David R. Fish (Editor), Emilio Perucca (Editor), W. Edwin Dodson (Editor). Published by Blackwell 2004. ISBN 0-632-06046-8
The Medical Treatment of Epilepsy by Stanley R Resor. Published by Marcel Dekker (1991). ISBN 0-8247-8549-5.
The Comparative Toxicogenomics Database: Metharbital

Clinical data
File:Metharbital.png
ATC code	N03AA30 (WHO)
Identifiers
IUPAC name 5,5-diethyl-1-methyl-hexahydropyrimidine-2,4,6-trione
CAS Number	50-11-3
PubChem CID	4099
DrugBank	APRD00757
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
Formula	C₉H₁₄N₂O₃
Molar mass	198.219 g/mol